Beximco Pharmaceuticals holds 48th AGM
The 48th Annual General Meeting of Beximco Pharmaceuticals Ltd. was held Virtually on Sunday, the 29th of December 2024.
Mr Iqbal Ahmed, Managing Director of the Company, presided over the meeting. Mr O K Chowdhury, Director, Mr A B Siddiqur Rahman, Director, Ms Quamrun Naher Ahmed, Director; Professor Mamtaz Uddin Ahmed, Independent Director, Dr Ibraheem Hosein Khan, Independent Director, Mr S M Rabbur Reza, Chief Operating Officer, Mr Ali Nawaz, Chief Financial Officer and Mr Mohammad Asad Ullah, Executive Director and Company Secretary attended the meeting.
Beximco Pharmaceuticals Limited declared a 40% Cash dividend for the year ended 30th June 2024 in its 48th Annual General Meeting.
Keep updated, follow The Business Standard's Google news channel
The Company achieved sales of Tk.44,391.60 million and earned a gross profit and net profit after tax of Tk.19,633.99 million and Tk.5,866.77 million, respectively, for the year ended 30th June 2024.
The Shareholders were highly satisfied with the Company's performance during the year.
They approved the Directors' Report and Audited Financial Statements for the year, which ended on 30th June, 2024, with a 40% cash dividend, and the appointment of Directors and Auditors for 2024-25.
